Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Dec;20(12):1801-4.
doi: 10.1007/s00467-005-2053-z. Epub 2005 Oct 14.

Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression

Sylvie Nathanson  1 , Pierre Cochat, Jean-Luc André, Claude Guyot, Chantal Loirat, Hubert Nivet, Georges Deschênes
Affiliations
Comparative Study

Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression

Sylvie Nathanson et al. Pediatr Nephrol. 2005 Dec.

Abstract

Recurrence of nephrotic syndrome after renal transplantation leads to graft loss within 1 year in 50-80% of patients who do not receive any specific treatment. Several treatment protocols have been proposed leading to long-term remission in 50-80% of patients. The aim of our study was to evaluate the efficiency of intensified immunosuppression, simultaneously including methylprednisolone pulses, cyclophosphamide, high-dose cyclosporine and plasma exchanges. Fourteen patients with early recurrence were treated with a protracted high-dose prednisone or IV methylprednisolone, oral cyclophosphamide, high-dose oral or IV cyclosporine, and plasma exchanges. By the end of cyclophosphamide therapy and plasma-exchange program, six out of 14 patients had no proteinuria; five had residual proteinuria without nephrotic syndrome and three experienced ongoing gross proteinuria with nephrotic syndrome. By the end of follow-up, four out of the 14 patients had lost their graft: one out of six with complete remission, one out of five with residual proteinuria and two out of three with persistent nephrotic syndrome. We conclude that multiple reinforcement of immunosuppression in patients with recurrent nephrotic syndrome following renal transplantation as performed in our patients is not more efficient than the single use of cyclophosphamide or plasma exchange or high-dose cyclosporine as reported in the literature.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Nephrol Dial Transplant. 2000 Jan;15(1):78-81 - PubMed
    1. Transplantation. 2001 Mar 15;71(5):628-33 - PubMed
    1. Contrib Nephrol. 1987;55:123-35 - PubMed
    1. Pediatr Transplant. 2001 Dec;5(6):406-9 - PubMed
    1. Transplantation. 2003 Mar 27;75(6):810-4 - PubMed

Publication types

MeSH terms

LinkOut - more resources